Characterization of Myocardial Infarction Scar Using Magnetic Resonance Imaging - Trial NCT05967026
Access comprehensive clinical trial information for NCT05967026 through Pure Global AI's free database. This phase not specified trial is sponsored by Central Hospital, Nancy, France and is currently Enrolling by invitation. The study focuses on Myocardial Infarction. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Central Hospital, Nancy, France
Timeline & Enrollment
N/A
Jul 01, 2023
Aug 01, 2023
Primary Outcome
Intramural scar surface in cm²
Summary
The goal of this monocentric observationnal study is to describe the characteristics of the
 myocardial infarction scar in terms of transmurality in residual LVEF35% patients.
 
 The primary objective is to determine the frequency of the criterion intramural scar
 ≥1.47cm2 (measured by MRI) in patients who presented with myocardial infarction with
 residual LVEF≥35%.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05967026
Non-Device Trial